RedHill Biopharma RDHL SEC Filings

NASDAQ RDHL
$0.69 +0.03 (+4.62%)
As of: Sep 9, 2026 · 3:09 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document RedHill Biopharma Ltd. (RDHL) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index